CRL vs HURA · rev $4.02B vs $125.1M cap
Charles River Laboratories (CRL) versus TuHURA Biosciences Inc (HURA) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
TuHURA Biosciences Inc (HURA) is a biotechnology company listed on US.
Latest reported CRL revenue for 2025-12-27 was $4.02B. Net income was -$144.3M. CRL currently screens at market cap $7.78B.
Latest reported HURA revenue for 2026-03-31 was $0. Net income was -$7.5M. HURA currently screens at market cap $125.1M.
CRL currently screens at market cap $7.78B. HURA currently screens at market cap $125.1M.
Not investment advice. Open the CRL and HURA stock pages for the full models.
Not investment advice.